The following genes and their expression levels were claimed to be related to poor outcome in patients with different types of cancers: hepatocellular carcinoma with high STK25 expression levels [42]; colorectal cancer with low ZC3H12A expression levels [43]; colon cancer with elevated HSPA1B expression levels [44]; lung adenocarcinoma with STK24 expression levels [45]. This evidence concerns the gene ZC3H12A and hepatocellular carcinoma.